Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 23.99%45.11M | 135.50%83.45M | -17.15%36.38M | -71.06%35.43M | -2.54%43.91M | -72.57%122.46M | -87.05%45.05M | -1.77%446.44M | 42.40%347.96M | 200.89%454.46M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 43.02%-8.75M | 42.96%-22.87M | 27.94%-15.36M | -51.20%-40.1M | ---21.32M | ---26.52M | ---- | ---- | ---- | ---- |
| Interest expense - adjustment | -52.70%19.8M | -31.53%61.58M | -6.25%41.87M | 71.42%89.94M | 197.03%44.66M | 205.80%52.47M | --15.04M | --17.16M | ---- | ---- |
| Attributable subsidiary (profit) loss | 71.46%-6.11M | -8,171.71%-29.53M | -490.16%-21.41M | 95.59%-357K | -31.98%5.49M | -142.97%-8.1M | 45.61%8.07M | --18.84M | 29.89%5.54M | ---- |
| Impairment and provisions: | 47.09%61.5M | 52.63%87.74M | 548.15%41.81M | 9.30%57.49M | -78.57%6.45M | -12.86%52.59M | 10.97%30.1M | 235.99%60.36M | -17.42%27.12M | -60.38%17.96M |
| -Other impairments and provisions | 47.09%61.5M | 52.63%87.74M | 548.15%41.81M | 9.30%57.49M | -78.57%6.45M | -12.86%52.59M | 10.97%30.1M | 235.99%60.36M | -17.42%27.12M | -60.38%17.96M |
| Revaluation surplus: | 97.02%-2.81M | 43.93%-81.05M | -55.02%-94.18M | -20.94%-144.56M | 11.23%-60.76M | 23.57%-119.53M | -143.42%-68.44M | -15.29%-156.4M | 77.77%-28.12M | -174.51%-135.65M |
| -Other fair value changes | 97.02%-2.81M | 43.93%-81.05M | -55.02%-94.18M | -20.94%-144.56M | 11.23%-60.76M | 23.57%-119.53M | -143.42%-68.44M | -15.29%-156.4M | 77.77%-28.12M | -174.51%-135.65M |
| Asset sale loss (gain): | -416.56%-842K | 86.95%-277K | 92.52%-163K | -73.59%-2.12M | -62.78%-2.18M | 99.63%-1.22M | 99.60%-1.34M | -1,540.85%-328.17M | ---332.17M | -804.57%-20M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---560K | ---560K | ---- | ---- | -802.12%-20M |
| -Loss (gain) on sale of property, machinery and equipment | -416.56%-842K | 38.72%-277K | 73.28%-163K | 31.83%-452K | 21.59%-610K | -115.26%-663K | ---778K | ---308K | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---1.67M | ---1.57M | ---- | ---- | ---327.86M | ---332.17M | ---- |
| Depreciation and amortization: | -6.52%72.01M | 1.55%153.25M | 4.47%77.03M | 35.19%150.91M | 45.52%73.74M | 15.07%111.63M | -1.80%50.67M | 8.83%97.01M | 19.92%51.6M | 17.29%89.14M |
| -Amortization of intangible assets | -5.58%8.55M | -0.84%18.06M | -1.90%9.06M | -21.26%18.21M | -32.65%9.23M | -2.96%23.13M | 23.88%13.71M | 93.61%23.83M | 111.05%11.06M | 95.23%12.31M |
| -Other depreciation and amortization | -3.05%51.17M | 11.20%105.62M | 20.76%52.78M | 117.59%94.98M | 197.82%43.71M | 19.52%43.65M | -37.18%14.68M | -36.34%36.52M | -22.30%23.36M | -0.16%57.37M |
| Financial expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 56.94%7.2M | 74.92%9.82M |
| Special items | 143.97%39.22M | 1.53%81.15M | -40.28%16.08M | 72.33%79.93M | -1.72%26.92M | -9.67%46.38M | 1.34%27.39M | -24.85%51.35M | 286.14%27.03M | 607.30%68.33M |
| Operating profit before the change of operating capital | 167.07%219.12M | 47.18%333.45M | -29.82%82.05M | -1.57%226.55M | 9.74%116.91M | 11.41%230.16M | 0.35%106.53M | -57.32%206.58M | -49.34%106.16M | 3.76%484.06M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -102.01%-7K | -78.84%882K | -85.30%348K | 27.81%4.17M | 143.62%2.37M | 158.66%3.26M | --972K | ---5.56M | ---- | ---- |
| Accounts receivable (increase)decrease | 26.00%-42.14M | 66.11%-24.35M | -120.78%-56.94M | -173.93%-71.84M | 71.93%-25.79M | 224.16%97.17M | ---91.88M | 26.57%-78.27M | ---- | ---106.59M |
| Accounts payable increase (decrease) | 68.05%-226.51M | -143.87%-441.96M | -478.81%-709.07M | 74.37%1.01B | 3,926.25%187.18M | -35.45%577.8M | -107.67%-4.89M | 82.01%895.16M | 140.97%63.81M | 2,635.54%491.82M |
| prepayments (increase)decrease | 436.68%1.17B | -319.73%-222.6M | -148.17%-346.82M | 122.25%101.31M | -177.01%-139.75M | -73.19%-455.32M | -0.62%181.48M | 73.93%-262.9M | 248.23%182.61M | -234.88%-1.01B |
| Special items for working capital changes | -215.73%-1.16B | 133.51%519.8M | 381.59%1B | -545.32%-1.55B | -170.57%-356.67M | 73.49%-240.36M | 77.21%-131.82M | -691.01%-906.5M | -728.79%-578.43M | 328.90%153.38M |
| Cash from business operations | -69.49%-44.18M | 158.31%165.23M | 87.92%-26.07M | -233.22%-283.38M | -457.23%-215.75M | 240.42%212.71M | 126.74%60.4M | -1,178.74%-151.49M | -1,098.35%-225.85M | -82.21%14.04M |
| Other taxs | -41.20%-2.65M | 38.91%-2.56M | 29.50%-1.87M | 38.91%-4.19M | 53.93%-2.66M | -10.10%-6.86M | -10.98%-5.77M | 62.60%-6.23M | 43.68%-5.2M | 25.10%-16.65M |
| Interest received - operating | -45.86%7.8M | -46.26%20.17M | -31.28%14.4M | 41.55%37.54M | 116.14%20.96M | 235.25%26.52M | 264.55%9.7M | 7.76%7.91M | -40.92%2.66M | 400.75%7.34M |
| Interest paid - operating | 51.02%-18.55M | 4.83%-63.93M | -11.50%-37.87M | -74.51%-67.18M | -150.45%-33.96M | -168.81%-38.49M | -88.37%-13.56M | -45.80%-14.32M | -56.94%-7.2M | -74.92%-9.82M |
| Net cash from operations | -12.00%-57.58M | 137.49%118.91M | 77.79%-51.41M | -263.60%-317.21M | -555.88%-231.42M | 218.13%193.89M | 121.55%50.76M | -3,124.44%-164.12M | -1,870.38%-235.58M | -109.69%-5.09M |
| Cash flow from investment activities | ||||||||||
| Loan receivable (increase) decrease | ---6.35M | 70.86%-11.07M | ---- | 50.00%-38M | ---20M | -312.21%-76M | --0 | 202.32%35.81M | --35.81M | ---35M |
| Decrease in deposits (increase) | ---- | 200.00%81M | --81M | ---81M | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | --24K | --4K | ---- | ---- | 400.00%15K | ---- | --3K | ---- | ---- |
| Purchase of fixed assets | -773.39%-11.52M | 58.12%-3.35M | -44.79%-1.32M | -1.69%-7.99M | 82.41%-911K | 72.85%-7.85M | 77.29%-5.18M | -93.38%-28.92M | -703.10%-22.8M | -76.23%-14.96M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---17.04M | ---17.04M | ---- | ---- | ---- |
| Sale of subsidiaries | ---1.51M | ---- | ---- | ---- | ---- | ---- | ---- | --86.44M | ---13.56M | ---- |
| Acquisition of subsidiaries | ---- | 14.61%-21.13M | 30.90%1.33M | 84.82%-24.74M | 100.62%1.01M | -91.71%-162.95M | ---162.95M | ---85M | ---- | ---- |
| Recovery of cash from investments | 1,089.79%12.12M | -94.53%1.02M | -72.58%1.02M | 494.13%18.61M | 18.61%3.72M | -92.87%3.13M | -16.16%3.13M | --43.94M | --3.74M | ---- |
| Cash on investment | -39.94%-20.34M | 78.61%-40.29M | 86.20%-14.54M | 14.37%-188.35M | 40.23%-105.36M | -12.45%-219.97M | -78.82%-176.29M | -245.75%-195.61M | -260.55%-98.58M | 89.45%-56.58M |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | 93.23%-6.64M | -194.41%-22.72M | -931.58%-98M | 384.32%24.06M |
| Net cash from investment operations | -140.89%-27.59M | 101.93%6.21M | 155.53%67.49M | 33.12%-321.46M | 66.70%-121.54M | -189.47%-480.67M | -88.72%-364.97M | -101.35%-166.05M | -387.35%-193.39M | 40.55%-82.47M |
| Net cash before financing | -629.50%-85.17M | 119.59%125.12M | 104.56%16.09M | -122.70%-638.67M | -12.33%-352.96M | 13.14%-286.79M | 26.75%-314.21M | -277.08%-330.18M | -1,526.45%-428.98M | -1.60%-87.56M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 1.25%531.93M | -3.15%1.07B | -14.96%525.38M | 13.63%1.1B | 66.16%617.8M | 53.95%968.8M | 81.54%371.8M | 173.61%629.3M | 924.00%204.8M | 16.46%230M |
| Refund | -14.12%-507.58M | 8.68%-914.27M | 11.72%-444.78M | -25.48%-1B | -43.27%-503.85M | -130.46%-797.91M | -116.99%-351.67M | -75.93%-346.22M | ---162.07M | -186.87%-196.8M |
| Issuing shares | --174.69M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 5,251.68%2.35B |
| Issuance of bonds | ---- | ---- | ---- | ---- | ---- | --470.97M | ---- | ---- | ---- | ---- |
| Dividends paid - financing | ---5.42M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Absorb investment income | --1M | ---- | ---- | ---- | ---- | ---- | ---- | --2.2M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | 98.52%-4.31M | -272.79%-542.34M | -825.73%-290.36M | 82.91%-145.48M | 92.78%-31.37M | -118.90%-851.42M | -44,490.76%-434.31M | -467.37%-388.96M | 98.37%-974K | 41.85%-68.56M |
| Other items of the financing business | ---4.58M | ---5.04M | ---- | ---- | ---- | ---15M | ---- | ---- | ---- | ---- |
| Net cash from financing operations | 179.43%176.44M | -479.27%-419.79M | -423.87%-222.12M | 71.52%-72.47M | 115.99%68.58M | -96.21%-254.42M | -1,573.82%-428.82M | -105.64%-129.67M | -98.12%29.1M | 4,820.93%2.3B |
| Effect of rate | -253.34%-2.82M | -67.10%2.48M | -88.62%1.84M | -89.93%7.54M | -54.44%16.16M | 404.33%74.85M | 319.80%35.46M | 77.78%-24.6M | -2,374.39%-16.13M | -11,938.72%-110.69M |
| Net Cash | 144.30%91.27M | 58.56%-294.67M | 27.55%-206.04M | -31.40%-711.14M | 61.73%-284.38M | -17.69%-541.21M | -85.81%-743.03M | -120.79%-459.85M | -126.25%-399.88M | 5,705.04%2.21B |
| Begining period cash | -32.91%595.72M | -44.21%887.91M | -44.21%887.91M | -22.66%1.59B | -22.66%1.59B | -19.06%2.06B | -19.06%2.06B | 476.08%2.54B | 476.08%2.54B | -8.03%441.32M |
| Cash at the end | 0.07%684.17M | -32.91%595.72M | -48.33%683.71M | -44.21%887.91M | -2.00%1.32B | -22.66%1.59B | -36.50%1.35B | -19.06%2.06B | 8.26%2.13B | 476.08%2.54B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.